Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

Academia-Industry Training India

The Academia-Industry Training (AIT) India programme empowers researchers from Switzerland and Nepal to transform their scientific discoveries into successful businesses. Whether you are conceptualizing a startup idea or have already launched a venture based on your applied research, AIT India provides the support you need to navigate the innovation ecosystems in both India and Switzerland, bringing your solution closer to market readiness.

For over a decade, AIT India has been supporting sciencepreneurs in advancing their startups and exploring new market opportunities. The programme is jointly funded by the Department of Science and Technology (DST) in India and the Swiss Leading House South Asia.

Together with our partners the Indian Institute of Management in Ahmadebad and STARTUP CAMPUS we design and execute this program to support participants in exploring the potential of their innovations in the Indian and Swiss markets.

AIT India alumni have successfully advanced their startups, expanded into new markets and developed innovative solutions in fields such as health, energy, sustainability and emerging technologies. Their achievements highlight the programme's role in accelerating science-based innovation and offer valuable insights into emerging technological trends.

AIT India 2026/27 cohort

Step into the world of our startup founders from Switzerland. Read what motivates them, what challenges them, and what keeps their vision alive. If you would like to learn more about the startup founders from India who participate in the AIT India 2026/27, visit our partner Swissnex in India’s web page. 

Alexander Breuss, calmea AG

“calmea builds a sensor that sits between the bedpost and frame, passively reading heart rate, breathing, and sleep stages and monitoring the bedroom environment. Nothing to wear or charge. By connecting to smart home devices, we use real-time physiological data to automatically optimize room conditions for perfect rest.”

Read the interview

Denis Cmunt, PanTELL platform by Arcuria

“PanTELL develops cancer therapies that can work for a wider range of genetic backgrounds. By building safety testing into the discovery process from the start, we aim to create treatments faster and reduce the risk of harmful effects.”

Read the interview

Mayank Kaushal, UrbanQ AI

“Urban decisions often rely on fragmented data and competing priorities. I am developing UrbanQ AI to help architects, landscape architects, urban designers, developers, real-estate teams and public agencies compare options using shared evidence. AI organises information and explains trade-offs for professional review.”

Read the interview

Harini Lakshminarayanan, MudraDx

“MudraDx addresses an important gap in the clinic that kidney cancer patients face, namely the lack of informative molecular biomarkers. Using patient blood, we aim to support risk stratification of patients, so that clinicians can decide who needs therapy and who can be spared from drug toxicity.”

Read the interview

Seyyedmaalek Momeni, SIMORGH Sarl

“Critical infrastructure rarely fails without precursors, yet conventional monitoring often misses weak early signals or cannot detect and localize them fast and precisely enough. SIMORGH turns crack- and damage-related signals into near-real-time, actionable insights, helping operators identify where damage starts, how it evolves, and what drives it.”

Read the interview

Manuel Carro Domínguez, OutBe Rhythms

“Poor sleep affects one in three people, accelerating dementia and cardiovascular disease, yet current solutions are split between inaccurate trackers and inaccessible clinical care. OutBe Rhythms aims to bridge this gap by combining advanced health monitoring through closed eyelids with tailored outpatient care.”

Read the interview

Matteo Frigelli, ReShape

“Children nowadays spend less time outdoors and more time focused on screens, and their eyes develop accordingly: by 2050, half the world is expected to have myopia and therefore need refractive correction. Today, that means glasses, contact lenses, or a laser that permanently removes tissue. ReShape corrects vision by strengthening the cornea rather than cutting with a laser – a less invasive alternative.”

Read the interview

Ngoc Minh Huong (Hailey) Le, AFhelios

“We have one planet to pass on to future generations, and I want to help build a world where they can thrive. My research is a step towards turning that vision into reality.”

Read the interview

Noël Marc Speck, CelluloseHeal

“My research addresses the unmet need for an advanced, bioactive, and sustainable wound dressing that stimulates chronic wound healing, a silent epidemic that affects up to 4 % of the global population.”

Read the interview

Sébastien Guilmot, Juvion Health Sciences

“Juvion closes the gap between lifespan and health span, how long we live versus how well we live by addressing the loss of mobility with age. Our research showed that age-related decline in neuron-muscle connectivity can be prevented, the foundation for HS1, our first supplement targeting the neuro-muscular junction.”

Read the interview

Eligibility Swiss-based applicants

Applications through the Swiss Leading House South Asia are open to Swiss-based sciencepreneurs across all scientific disciplines and fields of research.

Eligible applicants must:

AIT India brings together participants from Switzerland and India. Swiss participants are selected by the Swiss Leading House South Asia, while Indian participants are selected separately by the Indian Institute of Management Ahmedabad (IIMA).

If you meet these criteria, we look forward to receiving your application.

What’s in it for you?

Program information and documents

Application to the program is currently closed. 

Stay tuned, put your name on the mailing list, and follow us to receive all updates on the next edition of the AIT India program.

The current program edition 2026/27 consists of the following:

AIT India Alumni

Learn more about our alumni, their research, and startups.

In short: Academia-Industry Training India

Grant of CHF 10,000: compete for this grant to further develop and scale your innovation

Expenses covered: all expenses including food, accommodation, and transportation during the seminaries 

Program destinations: India and Switzerland

Call: 1 per year

Inspiration

Gain an insight into the Academia-Industry Training (AIT) program and hear directly from participants.

What happens when researchers and startup founders from two countries spend time learning from each other? Former participants reflect on their experiences with the Academia-Industry Training (AIT) program.
In this video, Heath Hartle, COO of Impli, talks about his participation in the 2024/25 edition of the program.
In this video, Claudia Bigoni, Founder and CEO of SaisiR, talks about her participation in the 2024/25 edition of the program.
In this video, Bilal Fares, Co-Founder and CEO of Azure Cell Therapies, talks about his participation in the 2024/25 edition of the program.
In this video, Timur Ashirov, Founder and CEO of SEPARATIC, talks about his participation in the 2024/25 edition of the program.
In this video, Deeksha Bhartiya, Founder of Genomiki Solutions, talks about her participation in the 2024/25 edition of the Academia-Industry Training (AIT) India program.
In this video, Anand Verma, Founder and CEO of Perovskia Solar, talks about his participation in the 2022 edition of the program.
In this video, Prachi Kharb, Director and COO of Life and Limb (India), talks about her participation in the 2022 edition of the program.

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.